Throughout her career in the pharmaceutical industry, Dr. Anna Beryozkina has belonged to professional organizations such as the American Society of Clinical Oncology and the American College of Rheumatology, presenting posters and abstracts for annual scientific conferences hosted by these groups. Dr. Anna Beryozkina’s areas of expertise range from research to the development of pharmaceuticals to treat cancer and rheumatoid arthritis.
In her work with Genentech, Inc., Dr. Anna Beryozkina has, in collaboration with team members from multiple divisions, managed protocol-related issues and assisted with strategy for the company's clinical study team working on large Phase II studies. She also has overseen medical data review, guided documentation drafts, and implemented strategies for meeting applicable regulations.
She holds a pharmaceutical doctorate from the Massachusetts College of Pharmacy and Health Sciences. Previously, she completed pre-pharmacy studies at the University of Pittsburgh and a bachelor's degree in philosophy and psychology from McGill University.
